CHRISTIAN GONZALEZ PADILLA

Dr. CHRISTIAN GONZALEZ PADILLA

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
DPDulman O. Pineda-De Paz
Dulman O. Pineda-De Paz
Jorge Eduardo Hernandez del RioJorge Eduardo Hernandez del Rio
Jorge Eduardo Hernandez del Rio
CPCHRISTIAN GONZALEZ PADILLA
CHRISTIAN GONZALEZ PADILLA
RERamón M. Esturau-Santaló
Ramón M. Esturau-Santaló
JRJoseph Romero-Palafox
Joseph Romero-Palafox
DMDavid Cardona Müller
David Cardona Müller
There are three major mechanical complications after acute myocardial infarction: left ventricular free-wall rupture, ventricular septum rupture and acute mitral valve regurgitation. The left ventricular free-wall rupture is a serious and often lethal complication following an ST elevation myocardial infarction. However, very rarely this rupture can be contained by the pericardium, forming a pseudoaneurysm. We report a case of a 66-year-old man with multiple cardiovascular risk factors and previous ST elevation myocardial infarction, complaining of atypical chest pain. His electrocardiogram was in normal sinus rhythm, with the presence of Q wave in inferior leads and T-wave inversion in lateral leads. A transthoracic echocardiogram showed a left ventricular pseudoaneurysm. In the coronary angiography, multi-vessel disease was found. On-pump CABG was performed and a posterolateral left ventricular giant pseudoaneurysm were observed. Due its “petrous” consistency it was impossible to perform an aneurysmectomy. The diagnosis of left ventricular pseudoaneurysm can be difficult, as patients often present either asymptomatic or with non-specific symptoms attributed to other causes. A multimodality imaging diagnostic approach can be necessary. Immediate surgery is considered the treatment of choice because untreated pseudoaneurysms have a high risk of rupture leading to cardiac tamponade, shock and death.

7 July 2015 in Current Cardiovascular Imaging Reports
Verified
Journal Article
Closed access
PDF file
EAErick Alexanderson-Rosas
Erick Alexanderson-Rosas
JCJosé Raúl Cruz-Mendoza
José Raúl Cruz-Mendoza
GGGerardo Yoshiaki Guinto-Nishimura
Gerardo Yoshiaki Guinto-Nishimura
CGCarlos Alberto Guízar-Sánchez
Carlos Alberto Guízar-Sánchez
SHSalvador Hernández-Sandoval
Salvador Hernández-Sandoval
AMAloha Meave-González
Aloha Meave-González

12 February 2026 in Life
Verified
Journal Article
Open access
PDF file
HMHaydee Ninette Morales-Vazquez
Haydee Ninette Morales-Vazquez
DMDavid Cardona Müller
David Cardona Müller
FPFernando Grover Páez
Fernando Grover Páez
CRCarlos Gerardo Ramos-Becerra
Carlos Gerardo Ramos-Becerra
EMErnesto Germán Cardona Muñoz
Ernesto Germán Cardona Muñoz
CGChristopher Josue Lopez Gradilla
Christopher Josue Lopez Gradilla
Background: Cardiac arrhythmias are a frequent complication of acute SARS-CoV-2 infection. However, their long-term prevalence and clinical determinants among patients with post-COVID-19 syndrome, especially those previously hospitalized, remain poorly defined. Objectives: To assess the prevalence and types of arrhythmias in long COVID patients following hospitalization and to identify associated clinical risk factors. Methods: In this cross-sectional study, 53 patients previously hospitalized with confirmed COVID-19 were evaluated ≥3 months post-infection. All participants underwent a standardized clinical assessment, 12-lead electrocardiography, and 24 h Holter monitoring. Logistic and Cox regression analyses were performed to identify predictors of arrhythmia. Results: Arrhythmias were identified in 41.5% (n = 22) of patients. Atrial fibrillation (32%) was the most frequent arrhythmia, followed by sinus bradycardia (27%) and sinus tachycardia (18%). Age (OR 1.06, 95% CI 1.01–1.10, p = 0.01) and length of hospital stay (OR 1.1, 95% CI 1.01–1.2, p = 0.04) were independently associated with arrhythmia. Biguanide (metformin) therapy was inversely associated with the occurrence of arrhythmia (Exp(B) = 0.017, p = 0.008). Dyspnea (82.4%) and palpitations (41.5%) were the most commonly reported symptoms. Conclusions: Arrhythmias are common in patients with long COVID following severe disease. Advanced age and prolonged hospitalization are significant risk factors, while biguanide use may offer a protective effect. These findings underscore the need for targeted cardiac surveillance in this population.

26 April 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
IGItzel Elizabeth Garibay-Padilla
Itzel Elizabeth Garibay-Padilla
Jorge Eduardo Hernandez del RioJorge Eduardo Hernandez del Rio
Jorge Eduardo Hernandez del Rio
DODayana Estefania Orozco-Sepulveda
Dayana Estefania Orozco-Sepulveda
CPCHRISTIAN GONZALEZ PADILLA
CHRISTIAN GONZALEZ PADILLA
TMTomas Miranda-Aquino
Tomas Miranda-Aquino
Jaime Briseno-RamirezJaime Briseno-Ramirez
Jaime Briseno-Ramirez
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases, and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Calibration was assessed with bootstrap calibration plots and the Hosmer–Lemeshow test. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9% in a young cohort (median 37 years) characterized by high hemodialysis prevalence (47.4%), substantial right-sided IE (46.4%), and Staphylococcus aureus predominance (32%) with no methicillin-resistant isolates. Vasopressor-requiring shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908), significantly outperforming RiskE (0.598) and ICE (0.632). The Bayesian WISCA identified multiple carbapenem-sparing and anti-MRSA–sparing regimens with adequate coverage (≥80%), particularly for community-acquired IE, supporting stewardship-oriented empirical selection. Coverage was consistently lower in healthcare-associated IE. Conclusions: A parsimonious three-variable model provided strong, locally valid mortality prediction in this hemodialysis-predominant, MRSA-free cohort, substantially outperforming European-derived scores. External validation in independent cohorts is required before clinical adoption. The Bayesian WISCA demonstrated that adequate empirical coverage is achievable without routine broad-spectrum agents, offering institution-specific guidance for stewardship-compatible regimen selection; multicenter validation is warranted.

27 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
IGItzel Elizabeth Garibay-Padilla
Itzel Elizabeth Garibay-Padilla
Jorge Eduardo Hernandez del RioJorge Eduardo Hernandez del Rio
Jorge Eduardo Hernandez del Rio
DODayana Estefania Orozco-Sepulveda
Dayana Estefania Orozco-Sepulveda
CPCHRISTIAN GONZALEZ PADILLA
CHRISTIAN GONZALEZ PADILLA
TMTomas Miranda-Aquino
Tomas Miranda-Aquino
Jaime Briseno-RamirezJaime Briseno-Ramirez
Jaime Briseno-Ramirez
Background/Objectives: Infective endocarditis (IE) carries substantial mortality, particularly in middle-income settings where patient profiles and microbial ecology differ from those of cohorts used to derive international prognostic scores. Syndrome-specific, locally grounded decision aids for empirical therapy are also scarce. We aimed to identify predictors of in-hospital mortality, externally evaluate the RiskE and ICE scores, and construct a Bayesian weighted-incidence syndromic combination antibiogram (WISCA) for IE. Methods: We conducted a retrospective cohort study of consecutive adults with definite or possible IE admitted between January 2019 and January 2026. Candidate predictors were screened in two phases and a clinically specified model was estimated with maximum-likelihood and Firth penalization, with 1000-replicate bootstrap optimism correction. Discrimination was compared against RiskE and ICE using DeLong’s test and reclassification metrics. For empirical coverage, we built a WISCA using identified pathogens, reporting both non-Bayesian bootstrap estimates and Bayesian hierarchical partial-pooling estimates with species- and antibiotic-level random intercepts; analyses were also stratified by IE type. Results: In-hospital mortality was 22.9%. Septic shock (Firth OR 9.23, 95% CI 2.40–40.61) and acute heart failure (OR 10.01, 95% CI 2.78–41.07) were the strongest independent predictors; the final model achieved an AUC of 0.922 (optimism-corrected 0.908) and outperformed RiskE (AUC 0.598) and ICE (AUC 0.632). Bayesian WISCA ranked vancomycin + gentamicin and meropenem + gentamicin highest (both 87.0%); several β-lactam–based combinations provided comparably high coverage without requiring routine carbapenems. Coverage was consistently higher for community-acquired than healthcare-associated IE. Conclusions: A simple variable model provided strong, locally valid mortality prediction and substantially outperformed international scores in this hemodialysis-predominant cohort. Bayesian WISCA offers stable, institution-specific empirical coverage estimates that can support stewardship-oriented regimen selection; multicenter validation is warranted.